ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR / PROKINECITINE 2-RECIPIENT ANTAGONIST

摘要

PROBLEM TO BE SOLVED: To provide a new means for therapy and diagnosis of endometriosis and endometroid carcinoma. SOLUTION: EG-VEGF polypeptide, prokinecitine 2 polypeptide, effector of EG-VEGF nucleic acid and prokinecitine 2 nucleic acid or the corresponding recipient is pharmaceutically used for therapy and diagnosis of endometriosis and endometroid carcinoma and therapy of unusual bleeding. Further, in order to diagnose the receptiveness, an amount of the EG-VEGF, prokinecitine 2 or EG-VEGF/prokinecitine 2 recipient is measured. COPYRIGHT: (C)2004,JPO